| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | FBN1 FBN2 MEGF6 MEGF8 PLA2G2D JAG1 LRP1 CBLC LTBP2 VWCE F9 FBN3 NOTCH4 LRP8 | 3.20e-07 | 749 | 71 | 14 | GO:0005509 |
| GeneOntologyMolecularFunction | alpha-L-arabinofuranosidase activity | 1.25e-05 | 2 | 71 | 2 | GO:0046556 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.54e-05 | 188 | 71 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 1.08e-04 | 532 | 71 | 9 | GO:0016755 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 2.39e-04 | 85 | 71 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 2.69e-04 | 473 | 71 | 8 | GO:0004842 | |
| GeneOntologyMolecularFunction | structural molecule activity | FRAS1 FBN1 FBN2 JAG1 OBSCN COL14A1 LTBP2 FBN3 NUP153 EPB42 OTOG | 2.90e-04 | 891 | 71 | 11 | GO:0005198 |
| GeneOntologyMolecularFunction | acyltransferase activity | 3.97e-04 | 775 | 71 | 10 | GO:0016746 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 4.56e-04 | 512 | 71 | 8 | GO:0019787 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 7.06e-04 | 49 | 71 | 3 | GO:0005547 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 8.04e-04 | 12 | 71 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.10e-03 | 14 | 71 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.45e-03 | 16 | 71 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 2.08e-03 | 372 | 71 | 6 | GO:0061630 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 2.27e-03 | 20 | 71 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | folic acid binding | 2.27e-03 | 20 | 71 | 2 | GO:0005542 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.51e-03 | 21 | 71 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 2.91e-03 | 398 | 71 | 6 | GO:0061659 | |
| GeneOntologyMolecularFunction | Notch binding | 4.13e-03 | 27 | 71 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | amide binding | 4.23e-03 | 299 | 71 | 5 | GO:0033218 | |
| GeneOntologyBiologicalProcess | arabinose metabolic process | 1.20e-05 | 2 | 72 | 2 | GO:0019566 | |
| GeneOntologyBiologicalProcess | vibrational conductance of sound to the inner ear | 1.20e-05 | 2 | 72 | 2 | GO:0055127 | |
| GeneOntologyBiologicalProcess | L-arabinose metabolic process | 1.20e-05 | 2 | 72 | 2 | GO:0046373 | |
| GeneOntologyBiologicalProcess | innate vocalization behavior | 3.60e-05 | 3 | 72 | 2 | GO:0098582 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 5.38e-05 | 494 | 72 | 9 | GO:0031346 | |
| GeneOntologyBiologicalProcess | astrocyte activation involved in immune response | 7.18e-05 | 4 | 72 | 2 | GO:0002265 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 7.18e-05 | 4 | 72 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | RNH1 MEGF8 PLXNC1 NTRK2 JAG1 LRP1 FOXP1 GRN PRAG1 ITGB2 EPB42 NOTCH4 LRP8 | 9.02e-05 | 1090 | 72 | 13 | GO:0022603 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.58e-04 | 445 | 72 | 8 | GO:0141091 | |
| GeneOntologyBiologicalProcess | aorta development | 1.77e-04 | 80 | 72 | 4 | GO:0035904 | |
| GeneOntologyBiologicalProcess | fusion of sperm to egg plasma membrane involved in single fertilization | 2.06e-04 | 33 | 72 | 3 | GO:0007342 | |
| GeneOntologyBiologicalProcess | response to growth factor | FBN1 FBN2 CRIM1 MEGF8 NTRK2 WFIKKN2 LRP1 KCP CBLC LTBP2 LRP8 | 2.30e-04 | 883 | 72 | 11 | GO:0070848 |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 2.71e-04 | 482 | 72 | 8 | GO:0007178 | |
| GeneOntologyBiologicalProcess | cell activation involved in immune response | 2.82e-04 | 365 | 72 | 7 | GO:0002263 | |
| GeneOntologyBiologicalProcess | plasma membrane fusion | 2.91e-04 | 37 | 72 | 3 | GO:0045026 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 3.02e-04 | 92 | 72 | 4 | GO:0048844 | |
| GeneOntologyBiologicalProcess | tube development | FBN1 RNH1 MEGF8 FOXP2 NTRK2 JAG1 LRP1 MUC19 FOXP1 PHF14 GRN ITGB2 ST14 NOTCH4 | 3.03e-04 | 1402 | 72 | 14 | GO:0035295 |
| GeneOntologyBiologicalProcess | mature B cell differentiation involved in immune response | 3.15e-04 | 38 | 72 | 3 | GO:0002313 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 3.32e-04 | 8 | 72 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 3.95e-04 | 41 | 72 | 3 | GO:0035909 | |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 4.82e-04 | 104 | 72 | 4 | GO:0042490 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell proliferation | 5.21e-04 | 45 | 72 | 3 | GO:0010464 | |
| GeneOntologyBiologicalProcess | mature B cell differentiation | 5.92e-04 | 47 | 72 | 3 | GO:0002335 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 6.48e-04 | 11 | 72 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 6.60e-04 | 421 | 72 | 7 | GO:0048638 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 6.82e-04 | 114 | 72 | 4 | GO:0050772 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | 6.84e-04 | 846 | 72 | 10 | GO:0120035 | |
| GeneOntologyBiologicalProcess | B cell differentiation | 6.89e-04 | 201 | 72 | 5 | GO:0030183 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 7.09e-04 | 850 | 72 | 10 | GO:0071363 | |
| GeneOntologyCellularComponent | microfibril | 1.09e-05 | 13 | 72 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | extracellular matrix | 8.03e-05 | 656 | 72 | 10 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 8.23e-05 | 658 | 72 | 10 | GO:0030312 | |
| GeneOntologyCellularComponent | cerebellar climbing fiber to Purkinje cell synapse | 6.31e-04 | 11 | 72 | 2 | GO:0150053 | |
| Domain | EGF-like_dom | ATRN FRAS1 FBN1 FBN2 MEGF6 MEGF8 TENM3 JAG1 TENM1 LRP1 ADAM29 LTBP2 C7 VWCE F9 FBN3 NOTCH4 OTOG LRP8 | 3.02e-20 | 249 | 69 | 19 | IPR000742 |
| Domain | EGF_3 | ATRN FBN1 FBN2 MEGF6 MEGF8 TENM3 JAG1 TENM1 LRP1 ADAM29 LTBP2 C7 VWCE F9 FBN3 NOTCH4 OTOG LRP8 | 3.16e-19 | 235 | 69 | 18 | PS50026 |
| Domain | EGF_1 | ATRN FBN1 FBN2 MEGF6 MEGF8 TENM3 JAG1 TENM1 LRP1 ADAM29 LTBP2 C7 VWCE ITGB2 F9 FBN3 NOTCH4 LRP8 | 1.38e-18 | 255 | 69 | 18 | PS00022 |
| Domain | EGF-like_CS | ATRN FBN1 FBN2 MEGF6 MEGF8 TENM3 JAG1 TENM1 LRP1 ADAM29 LTBP2 C7 VWCE ITGB2 F9 FBN3 NOTCH4 LRP8 | 2.09e-18 | 261 | 69 | 18 | IPR013032 |
| Domain | EGF_2 | ATRN FBN1 FBN2 MEGF6 MEGF8 TENM3 JAG1 TENM1 LRP1 ADAM29 LTBP2 C7 VWCE ITGB2 F9 FBN3 NOTCH4 LRP8 | 2.75e-18 | 265 | 69 | 18 | PS01186 |
| Domain | EGF | ATRN FRAS1 FBN1 FBN2 MEGF6 MEGF8 TENM3 JAG1 TENM1 LRP1 LTBP2 VWCE F9 FBN3 NOTCH4 LRP8 | 2.50e-16 | 235 | 69 | 16 | SM00181 |
| Domain | Growth_fac_rcpt_ | ATRN FRAS1 FBN1 FBN2 CRIM1 MEGF6 MEGF8 JAG1 LRP1 LTBP2 VWCE FBN3 NOTCH4 LRP8 | 4.63e-16 | 156 | 69 | 14 | IPR009030 |
| Domain | EGF_Ca-bd_CS | FBN1 FBN2 MEGF6 MEGF8 JAG1 LRP1 LTBP2 VWCE F9 FBN3 NOTCH4 LRP8 | 1.32e-15 | 97 | 69 | 12 | IPR018097 |
| Domain | EGF_CA | FBN1 FBN2 MEGF6 MEGF8 JAG1 LRP1 LTBP2 VWCE F9 FBN3 NOTCH4 LRP8 | 1.70e-15 | 99 | 69 | 12 | PS01187 |
| Domain | ASX_HYDROXYL | FBN1 FBN2 MEGF6 MEGF8 JAG1 LRP1 LTBP2 VWCE F9 FBN3 NOTCH4 LRP8 | 1.93e-15 | 100 | 69 | 12 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | FBN1 FBN2 MEGF6 MEGF8 JAG1 LRP1 LTBP2 VWCE F9 FBN3 NOTCH4 LRP8 | 3.97e-15 | 106 | 69 | 12 | IPR000152 |
| Domain | EGF_CA | 1.49e-14 | 86 | 69 | 11 | PF07645 | |
| Domain | EGF_CA | FBN1 FBN2 MEGF6 MEGF8 JAG1 LRP1 LTBP2 VWCE F9 FBN3 NOTCH4 LRP8 | 2.24e-14 | 122 | 69 | 12 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | FBN1 FBN2 MEGF6 MEGF8 JAG1 LRP1 LTBP2 VWCE F9 FBN3 NOTCH4 LRP8 | 2.73e-14 | 124 | 69 | 12 | IPR001881 |
| Domain | VWC_out | 3.34e-13 | 19 | 69 | 7 | SM00215 | |
| Domain | VWF_dom | 1.67e-10 | 42 | 69 | 7 | IPR001007 | |
| Domain | EGF | 8.74e-10 | 126 | 69 | 9 | PF00008 | |
| Domain | EGF_extracell | 2.27e-09 | 60 | 69 | 7 | IPR013111 | |
| Domain | EGF_2 | 2.27e-09 | 60 | 69 | 7 | PF07974 | |
| Domain | VWC | 5.12e-09 | 38 | 69 | 6 | SM00214 | |
| Domain | TB | 5.92e-09 | 7 | 69 | 4 | PF00683 | |
| Domain | - | 1.18e-08 | 8 | 69 | 4 | 3.90.290.10 | |
| Domain | TB | 2.12e-08 | 9 | 69 | 4 | PS51364 | |
| Domain | TB_dom | 2.12e-08 | 9 | 69 | 4 | IPR017878 | |
| Domain | FBN | 4.83e-08 | 3 | 69 | 3 | IPR011398 | |
| Domain | hEGF | 5.46e-08 | 28 | 69 | 5 | PF12661 | |
| Domain | VWFC_2 | 2.71e-07 | 38 | 69 | 5 | PS50184 | |
| Domain | cEGF | 2.40e-06 | 26 | 69 | 4 | IPR026823 | |
| Domain | cEGF | 2.40e-06 | 26 | 69 | 4 | PF12662 | |
| Domain | VWC | 3.27e-06 | 28 | 69 | 4 | PF00093 | |
| Domain | VWFC_1 | 9.19e-06 | 36 | 69 | 4 | PS01208 | |
| Domain | - | 1.27e-05 | 39 | 69 | 4 | 2.120.10.30 | |
| Domain | Unchr_dom_Cys-rich | 1.34e-05 | 13 | 69 | 3 | IPR014853 | |
| Domain | C8 | 1.34e-05 | 13 | 69 | 3 | SM00832 | |
| Domain | LDLR_class-A_CS | 1.41e-05 | 40 | 69 | 4 | IPR023415 | |
| Domain | TIL_dom | 1.71e-05 | 14 | 69 | 3 | IPR002919 | |
| Domain | PSI | 2.07e-05 | 44 | 69 | 4 | IPR016201 | |
| Domain | Ldl_recept_a | 2.27e-05 | 45 | 69 | 4 | PF00057 | |
| Domain | PSI | 2.48e-05 | 46 | 69 | 4 | SM00423 | |
| Domain | - | 2.48e-05 | 46 | 69 | 4 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.48e-05 | 46 | 69 | 4 | IPR011042 | |
| Domain | VWD | 2.61e-05 | 16 | 69 | 3 | SM00216 | |
| Domain | VWF_type-D | 2.61e-05 | 16 | 69 | 3 | IPR001846 | |
| Domain | VWFD | 2.61e-05 | 16 | 69 | 3 | PS51233 | |
| Domain | VWD | 2.61e-05 | 16 | 69 | 3 | PF00094 | |
| Domain | LDLRA_1 | 2.94e-05 | 48 | 69 | 4 | PS01209 | |
| Domain | LDLRA_2 | 3.19e-05 | 49 | 69 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 3.19e-05 | 49 | 69 | 4 | IPR002172 | |
| Domain | LDLa | 3.19e-05 | 49 | 69 | 4 | SM00192 | |
| Domain | Tox-GHH_dom | 8.03e-05 | 4 | 69 | 2 | IPR028916 | |
| Domain | Ten_N | 8.03e-05 | 4 | 69 | 2 | IPR009471 | |
| Domain | FOXP-CC | 8.03e-05 | 4 | 69 | 2 | PF16159 | |
| Domain | Ten_N | 8.03e-05 | 4 | 69 | 2 | PF06484 | |
| Domain | FOXP-CC | 8.03e-05 | 4 | 69 | 2 | IPR032354 | |
| Domain | TENEURIN_N | 8.03e-05 | 4 | 69 | 2 | PS51361 | |
| Domain | Tox-GHH | 8.03e-05 | 4 | 69 | 2 | PF15636 | |
| Domain | Folate_rcpt | 1.34e-04 | 5 | 69 | 2 | IPR004269 | |
| Domain | YD | 1.34e-04 | 5 | 69 | 2 | IPR006530 | |
| Domain | PSI | 2.22e-04 | 32 | 69 | 3 | PF01437 | |
| Domain | Plexin_repeat | 2.22e-04 | 32 | 69 | 3 | IPR002165 | |
| Domain | Laminin_EGF | 2.90e-04 | 35 | 69 | 3 | PF00053 | |
| Domain | EGF_Lam | 2.90e-04 | 35 | 69 | 3 | SM00180 | |
| Domain | Laminin_EGF | 3.71e-04 | 38 | 69 | 3 | IPR002049 | |
| Domain | Folate_rcpt-like | 3.71e-04 | 8 | 69 | 2 | IPR018143 | |
| Domain | Folate_rec | 3.71e-04 | 8 | 69 | 2 | PF03024 | |
| Domain | Integin_beta_N | 4.76e-04 | 9 | 69 | 2 | IPR033760 | |
| Domain | PSI_integrin | 4.76e-04 | 9 | 69 | 2 | PF17205 | |
| Domain | - | 7.41e-04 | 48 | 69 | 3 | 2.120.10.80 | |
| Domain | CUB | 7.87e-04 | 49 | 69 | 3 | PF00431 | |
| Domain | CUB | 8.35e-04 | 50 | 69 | 3 | SM00042 | |
| Domain | TIL | 8.67e-04 | 12 | 69 | 2 | PF01826 | |
| Domain | C8 | 8.67e-04 | 12 | 69 | 2 | PF08742 | |
| Domain | - | 9.37e-04 | 52 | 69 | 3 | 2.60.120.290 | |
| Domain | CUB | 9.90e-04 | 53 | 69 | 3 | PS01180 | |
| Domain | NHL | 1.02e-03 | 13 | 69 | 2 | PS51125 | |
| Domain | Kelch-typ_b-propeller | 1.10e-03 | 55 | 69 | 3 | IPR015915 | |
| Domain | Ldl_recept_b | 1.19e-03 | 14 | 69 | 2 | PF00058 | |
| Domain | LDLRB | 1.19e-03 | 14 | 69 | 2 | PS51120 | |
| Domain | CUB_dom | 1.22e-03 | 57 | 69 | 3 | IPR000859 | |
| Domain | Gal_Oxase/kelch_b-propeller | 1.35e-03 | 59 | 69 | 3 | IPR011043 | |
| Domain | LY | 1.37e-03 | 15 | 69 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.37e-03 | 15 | 69 | 2 | IPR000033 | |
| Domain | CT | 2.96e-03 | 22 | 69 | 2 | SM00041 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 2.29e-06 | 25 | 54 | 4 | M39713 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.16e-05 | 37 | 54 | 4 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.33e-05 | 44 | 54 | 4 | M26969 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.44e-04 | 32 | 54 | 3 | MM14854 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.39e-04 | 258 | 54 | 6 | MM14572 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.40e-04 | 39 | 54 | 3 | MM14601 | |
| Pubmed | 2.23e-09 | 9 | 73 | 4 | 12122015 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 3.54e-08 | 4 | 73 | 3 | 25034023 | |
| Pubmed | 1.90e-07 | 118 | 73 | 6 | 21078624 | ||
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 5.38e-07 | 31 | 73 | 4 | 31550482 | |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 1.43e-06 | 91 | 73 | 5 | 28558017 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.56e-06 | 184 | 73 | 6 | 32908313 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 12399449 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 21851253 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 12429739 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 30031127 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 36044575 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 4.35e-06 | 2 | 73 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 4.35e-06 | 2 | 73 | 2 | 21440062 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15131124 | ||
| Pubmed | Foxp2 regulates anatomical features that may be relevant for vocal behaviors and bipedal locomotion. | 4.35e-06 | 2 | 73 | 2 | 30104377 | |
| Pubmed | LDL-receptor-related protein regulates beta2-integrin-mediated leukocyte adhesion. | 4.35e-06 | 2 | 73 | 2 | 15328156 | |
| Pubmed | Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. | 4.35e-06 | 2 | 73 | 2 | 12871934 | |
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 4.35e-06 | 2 | 73 | 2 | 12524050 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 26387946 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 4.35e-06 | 2 | 73 | 2 | 20404337 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 4.35e-06 | 2 | 73 | 2 | 8791520 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 22028443 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 8120105 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 35419902 | ||
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 4.35e-06 | 2 | 73 | 2 | 8307578 | |
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 4.35e-06 | 2 | 73 | 2 | 10504303 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15221638 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 4.35e-06 | 2 | 73 | 2 | 7744963 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 4.35e-06 | 2 | 73 | 2 | 18006876 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 4.35e-06 | 2 | 73 | 2 | 24833718 | |
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 4.35e-06 | 2 | 73 | 2 | 24484584 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 24893771 | ||
| Pubmed | Foxp1 is an essential transcriptional regulator of B cell development. | 4.35e-06 | 2 | 73 | 2 | 16819554 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 24265020 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 20529844 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 4.35e-06 | 2 | 73 | 2 | 25524144 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 9451590 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 12522212 | ||
| Pubmed | Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction. | 4.35e-06 | 2 | 73 | 2 | 15056695 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 23133647 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 24378291 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 25853299 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 27224915 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 11358962 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 24867584 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 28741757 | ||
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 4.35e-06 | 2 | 73 | 2 | 16407178 | |
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 4.35e-06 | 2 | 73 | 2 | 1852206 | |
| Pubmed | Compensation between FOXP transcription factors maintains proper striatal function. | 4.35e-06 | 2 | 73 | 2 | 38761373 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 10359653 | ||
| Pubmed | ASAP3 is a focal adhesion-associated Arf GAP that functions in cell migration and invasion. | 4.35e-06 | 2 | 73 | 2 | 18400762 | |
| Pubmed | The mouse tight skin (Tsk) phenotype is not dependent on the presence of mature T and B lymphocytes. | 4.35e-06 | 2 | 73 | 2 | 9799844 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 26647308 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ATRN FRAS1 FBN1 FBN2 ERO1B CRIM1 MEGF8 TENM3 LRP1 GRN LTBP2 LRP8 | 7.16e-06 | 1201 | 73 | 12 | 35696571 |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 25546260 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 10825173 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 14516685 | ||
| Pubmed | Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo. | 1.30e-05 | 3 | 73 | 2 | 24251389 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 26341090 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 30201140 | ||
| Pubmed | Human-specific transcriptional regulation of CNS development genes by FOXP2. | 1.30e-05 | 3 | 73 | 2 | 19907493 | |
| Pubmed | Establishment of tumor-associated immunity requires interaction of heat shock proteins with CD91. | 1.30e-05 | 3 | 73 | 2 | 24778318 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 21676865 | ||
| Pubmed | Folate Receptor β Regulates Integrin CD11b/CD18 Adhesion of a Macrophage Subset to Collagen. | 1.30e-05 | 3 | 73 | 2 | 27534550 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 14988227 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 28507505 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 37928524 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 15939383 | ||
| Pubmed | Magnesium sensing via LFA-1 regulates CD8+ T cell effector function. | 1.30e-05 | 3 | 73 | 2 | 35051368 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 12522143 | ||
| Pubmed | Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. | 1.30e-05 | 3 | 73 | 2 | 12687690 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 17293099 | ||
| Pubmed | Transcriptional regulation by FOXP1, FOXP2, and FOXP4 dimerization. | 1.30e-05 | 3 | 73 | 2 | 25027557 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 12807892 | ||
| Pubmed | Foxp1 expression is essential for sex-specific murine neonatal ultrasonic vocalization. | 1.30e-05 | 3 | 73 | 2 | 28204507 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 20855508 | ||
| Pubmed | 1.73e-05 | 257 | 73 | 6 | 16335952 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 2.23e-05 | 26 | 73 | 3 | 34189436 | |
| Pubmed | 2.39e-05 | 407 | 73 | 7 | 12693553 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 12429738 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 14701752 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 2.60e-05 | 4 | 73 | 2 | 10225957 | |
| Pubmed | Human eye development is characterized by coordinated expression of fibrillin isoforms. | 2.60e-05 | 4 | 73 | 2 | 25406291 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 21540769 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 20729550 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 17984306 | ||
| Pubmed | Identification of two putative novel folate receptor genes in humans and mouse. | 2.60e-05 | 4 | 73 | 2 | 11111049 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 16835936 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 20301293 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 36376768 | ||
| Pubmed | Extrinsic Regulators of mRNA Translation in Developing Brain: Story of WNTs. | 2.60e-05 | 4 | 73 | 2 | 33525513 | |
| Pubmed | Identification and characterization of T reg-like cells in zebrafish. | 2.60e-05 | 4 | 73 | 2 | 29066577 | |
| Pubmed | Complement receptor 3 (CD11b/CD18) is implicated in the elimination of β-amyloid peptides. | 2.60e-05 | 4 | 73 | 2 | 20199584 | |
| Pubmed | FOXP1 Promotes Embryonic Neural Stem Cell Differentiation by Repressing Jagged1 Expression. | 2.60e-05 | 4 | 73 | 2 | 29141232 | |
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 2.60e-05 | 4 | 73 | 2 | 12000766 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 29719266 | ||
| Pubmed | Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. | 2.76e-05 | 82 | 73 | 4 | 31073041 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 3.33e-05 | 86 | 73 | 4 | 28327460 | |
| Pubmed | 3.47e-05 | 175 | 73 | 5 | 28071719 | ||
| Interaction | FBXO2 interactions | ATRN FRAS1 FBN1 FBN2 ERO1B MEGF8 TENM3 PLXNC1 JAG1 COL14A1 GRN ST14 | 1.61e-08 | 411 | 70 | 12 | int:FBXO2 |
| Interaction | ZNF408 interactions | 7.08e-07 | 145 | 70 | 7 | int:ZNF408 | |
| Interaction | MFAP5 interactions | 1.00e-06 | 52 | 70 | 5 | int:MFAP5 | |
| Interaction | ZFP41 interactions | 1.59e-06 | 57 | 70 | 5 | int:ZFP41 | |
| Interaction | FBN2 interactions | 3.07e-06 | 65 | 70 | 5 | int:FBN2 | |
| Interaction | IGFL3 interactions | 6.25e-06 | 75 | 70 | 5 | int:IGFL3 | |
| Interaction | MFAP2 interactions | 8.63e-06 | 12 | 70 | 3 | int:MFAP2 | |
| Interaction | ZNF444 interactions | 3.38e-05 | 106 | 70 | 5 | int:ZNF444 | |
| Interaction | ATXN7 interactions | 3.86e-05 | 109 | 70 | 5 | int:ATXN7 | |
| Interaction | LYZL1 interactions | 5.65e-05 | 118 | 70 | 5 | int:LYZL1 | |
| Interaction | CACNA1A interactions | 6.88e-05 | 123 | 70 | 5 | int:CACNA1A | |
| Interaction | NTN5 interactions | 7.71e-05 | 24 | 70 | 3 | int:NTN5 | |
| Interaction | ST14 interactions | 8.29e-05 | 207 | 70 | 6 | int:ST14 | |
| Interaction | ZSCAN21 interactions | 8.31e-05 | 128 | 70 | 5 | int:ZSCAN21 | |
| Interaction | CTU1 interactions | 1.42e-04 | 76 | 70 | 4 | int:CTU1 | |
| Interaction | SLURP1 interactions | 1.45e-04 | 144 | 70 | 5 | int:SLURP1 | |
| Interaction | EGFL7 interactions | 1.49e-04 | 77 | 70 | 4 | int:EGFL7 | |
| Interaction | ZNF664 interactions | 1.68e-04 | 31 | 70 | 3 | int:ZNF664 | |
| Interaction | PRELP interactions | 1.85e-04 | 32 | 70 | 3 | int:PRELP | |
| GeneFamily | Low density lipoprotein receptors | 4.85e-04 | 13 | 46 | 2 | 634 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 8.41e-04 | 17 | 46 | 2 | 1291 | |
| GeneFamily | ArfGAPs | 3.18e-03 | 33 | 46 | 2 | 395 | |
| GeneFamily | Complement system|Sushi domain containing | 3.78e-03 | 36 | 46 | 2 | 492 | |
| GeneFamily | Ring finger proteins | 5.18e-03 | 275 | 46 | 4 | 58 | |
| GeneFamily | Forkhead boxes | 5.35e-03 | 43 | 46 | 2 | 508 | |
| Coexpression | NABA_MATRISOME | FRAS1 FBN1 FBN2 CRIM1 MEGF6 MEGF8 OTOGL PLXNC1 WFIKKN2 MUC19 KCP COL14A1 ADAM29 LTBP2 VWCE F9 ST14 OTOG | 1.70e-10 | 1008 | 72 | 18 | MM17056 |
| Coexpression | NABA_MATRISOME | FRAS1 FBN1 FBN2 CRIM1 MEGF6 MEGF8 PLXNC1 WFIKKN2 MUC19 KCP COL14A1 ADAM29 LTBP2 VWCE F9 ST14 FBN3 OTOG | 2.26e-10 | 1026 | 72 | 18 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.75e-09 | 191 | 72 | 9 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.45e-09 | 196 | 72 | 9 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 3.48e-09 | 270 | 72 | 10 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 4.15e-09 | 275 | 72 | 10 | M5884 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 7.60e-06 | 261 | 72 | 7 | M1834 | |
| Coexpression | RODWELL_AGING_KIDNEY_UP | 9.27e-06 | 501 | 72 | 9 | M5389 | |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP | 1.88e-05 | 200 | 72 | 6 | M6200 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 3.83e-05 | 137 | 72 | 5 | M40313 | |
| Coexpression | BROWNE_HCMV_INFECTION_30MIN_DN | 5.02e-05 | 145 | 72 | 5 | M0 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 5.27e-05 | 482 | 72 | 8 | M12144 | |
| Coexpression | DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP | 7.78e-05 | 159 | 72 | 5 | M34031 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 1.01e-04 | 168 | 72 | 5 | M1124 | |
| Coexpression | JONES_OVARY_NK_CELL | 1.07e-04 | 89 | 72 | 4 | M48353 | |
| Coexpression | GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP | 1.19e-04 | 174 | 72 | 5 | M333 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 1.45e-04 | 289 | 72 | 6 | M41750 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 1.47e-04 | 182 | 72 | 5 | MM993 | |
| Coexpression | LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED | 1.56e-04 | 38 | 72 | 3 | M39244 | |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN | 2.12e-04 | 197 | 72 | 5 | M3465 | |
| Coexpression | GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN | 2.17e-04 | 198 | 72 | 5 | M4959 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP | 2.27e-04 | 200 | 72 | 5 | M6418 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN | 2.27e-04 | 200 | 72 | 5 | M5977 | |
| Coexpression | GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP | 2.27e-04 | 200 | 72 | 5 | M7147 | |
| Coexpression | GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP | 2.27e-04 | 200 | 72 | 5 | M7159 | |
| Coexpression | GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN | 2.27e-04 | 200 | 72 | 5 | M6715 | |
| Coexpression | GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN | 2.27e-04 | 200 | 72 | 5 | M7373 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 2.46e-04 | 767 | 72 | 9 | M39209 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 3.07e-04 | 117 | 72 | 4 | M39300 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_MESENCHYMAL | 3.24e-04 | 216 | 72 | 5 | M2122 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.33e-08 | 188 | 72 | 7 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.99e-08 | 195 | 72 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.99e-08 | 195 | 72 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.32e-08 | 198 | 72 | 7 | a35b43d38e18c6f8f0cd9015b8e23f71c729f023 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 3.88e-07 | 174 | 72 | 6 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.29e-07 | 177 | 72 | 6 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 4.29e-07 | 177 | 72 | 6 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-07 | 184 | 72 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-07 | 184 | 72 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-07 | 184 | 72 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-07 | 185 | 72 | 6 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-07 | 185 | 72 | 6 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-07 | 186 | 72 | 6 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.74e-07 | 186 | 72 | 6 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.11e-07 | 188 | 72 | 6 | fcf1bebef7aa81b4a11c1f9e4319339c290ecd22 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.70e-07 | 191 | 72 | 6 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.70e-07 | 191 | 72 | 6 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.56e-07 | 195 | 72 | 6 | eb104f3bb08ab9eca31273c0523a5c90de1f30a9 | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.79e-07 | 196 | 72 | 6 | e4f40274df940e0996c555082f2bb4f99e5b0881 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.26e-07 | 198 | 72 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.26e-07 | 198 | 72 | 6 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.26e-07 | 198 | 72 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.51e-07 | 199 | 72 | 6 | 372fb9eb90022dc4ac770a75b4e207c33d1d0c43 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.51e-07 | 199 | 72 | 6 | dd3bf59cdc18091889cbf6c43f37100ba537843d | |
| ToppCell | cellseq2-Immune-Immune_Myeloid|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.51e-07 | 199 | 72 | 6 | 6c3c9eceea20121ae17ae2462134aa0437f591b3 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-07 | 199 | 72 | 6 | 368e2bafae00ce8e9c6ea480f81b78f96b680acd | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-07 | 200 | 72 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-07 | 200 | 72 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-07 | 200 | 72 | 6 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-07 | 200 | 72 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-07 | 200 | 72 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.76e-07 | 200 | 72 | 6 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-07 | 200 | 72 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-07 | 200 | 72 | 6 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-07 | 200 | 72 | 6 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-06 | 160 | 72 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-06 | 160 | 72 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-06 | 161 | 72 | 5 | 441ebd3c029861d833fbcf8a68fc740d9de8ef2f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.82e-06 | 168 | 72 | 5 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.28e-06 | 170 | 72 | 5 | af8b56555cbd5a1016ab9ec2ce88225c58c89648 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.52e-06 | 171 | 72 | 5 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.01e-06 | 173 | 72 | 5 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM4-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.27e-06 | 174 | 72 | 5 | fe105550a43b935affc73e32796115d20328a2f8 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM4|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.27e-06 | 174 | 72 | 5 | 9191f6abb37ca65da5105f91e21689d11ec1059b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-06 | 175 | 72 | 5 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.53e-06 | 175 | 72 | 5 | b2099b4ab1bf74497f454a99fffe5f5561b1f968 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM4-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.53e-06 | 175 | 72 | 5 | 6e54b74c735f249c7bfab7087c1638065ec1dd2e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 177 | 72 | 5 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | BAL-Control-Myeloid-Macrophage|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.18e-05 | 183 | 72 | 5 | 8e9d45c96b44558158e3d59613f64a73d5390c19 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.18e-05 | 183 | 72 | 5 | 0408d991ddb639594b45d5cb2432dd29289167b1 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.18e-05 | 183 | 72 | 5 | 79f05b8a967124d831b0baef137e30659f5917a7 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.21e-05 | 184 | 72 | 5 | 92202e1cd0bba1ce4b061ebcb8a2af5bb590542a | |
| ToppCell | BAL-Control-Myeloid-Macrophage|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.21e-05 | 184 | 72 | 5 | 7331535d469453a5264dcb0270a97f63d3b55201 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.21e-05 | 184 | 72 | 5 | 337e38a6b2b6770cc992d88b006829f194841b10 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.25e-05 | 185 | 72 | 5 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.25e-05 | 185 | 72 | 5 | 506eee2c1b6e8acec3aa8b2c66868010006c4c14 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.25e-05 | 185 | 72 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.25e-05 | 185 | 72 | 5 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-05 | 186 | 72 | 5 | 96f6603cc75fa1ffc2a2fdb94ec0ec09498e540a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.31e-05 | 187 | 72 | 5 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-05 | 187 | 72 | 5 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.31e-05 | 187 | 72 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 187 | 72 | 5 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.35e-05 | 188 | 72 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 1.35e-05 | 188 | 72 | 5 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 1.38e-05 | 189 | 72 | 5 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 189 | 72 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 189 | 72 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-05 | 189 | 72 | 5 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 190 | 72 | 5 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 190 | 72 | 5 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 190 | 72 | 5 | d13fd234caa3fc69d8a59bc0060cdacdf716ee55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 190 | 72 | 5 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 190 | 72 | 5 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 191 | 72 | 5 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | Control-Myeloid-transitional_Macro|Control / Disease group,lineage and cell class (2021.01.30) | 1.45e-05 | 191 | 72 | 5 | 3ed0b1ff628a165e3c92c2e493206015f57dccfe | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-05 | 191 | 72 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-05 | 191 | 72 | 5 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-05 | 191 | 72 | 5 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.45e-05 | 191 | 72 | 5 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 191 | 72 | 5 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-05 | 191 | 72 | 5 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-05 | 191 | 72 | 5 | b270c3dd5952f56b9bdceabe13e298fe6757563b | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.45e-05 | 191 | 72 | 5 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-05 | 191 | 72 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 191 | 72 | 5 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 192 | 72 | 5 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-05 | 192 | 72 | 5 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 192 | 72 | 5 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 192 | 72 | 5 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 192 | 72 | 5 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 192 | 72 | 5 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-05 | 192 | 72 | 5 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-05 | 192 | 72 | 5 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.49e-05 | 192 | 72 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-05 | 192 | 72 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-05 | 192 | 72 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 192 | 72 | 5 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 192 | 72 | 5 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-05 | 192 | 72 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| Computational | Placenta genes. | 5.91e-05 | 463 | 42 | 9 | MODULE_38 | |
| Drug | Acyclovir [59277-89-3]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 2.99e-06 | 197 | 72 | 7 | 1543_UP | |
| Disease | connective tissue disease (implicated_via_orthology) | 1.28e-08 | 3 | 70 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | dementia (is_implicated_in) | 2.77e-06 | 12 | 70 | 3 | DOID:1307 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome | 1.66e-05 | 3 | 70 | 2 | C0265313 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 1.66e-05 | 3 | 70 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 1.66e-05 | 3 | 70 | 2 | C1869114 | |
| Disease | specific developmental disorder (implicated_via_orthology) | 3.32e-05 | 4 | 70 | 2 | DOID:0060038 (implicated_via_orthology) | |
| Disease | scoliosis (is_implicated_in) | 3.32e-05 | 4 | 70 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome | 3.32e-05 | 4 | 70 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 3.32e-05 | 4 | 70 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | schizophrenia (is_implicated_in) | 3.63e-05 | 78 | 70 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | pulse pressure measurement | PAQR9 FBN1 FBN2 NEURL3 CRIM1 MEGF8 PLXNC1 JAG1 LRP1 FOXP1 LTBP2 OBI1 | 9.74e-05 | 1392 | 70 | 12 | EFO_0005763 |
| Disease | aortic aneurysm | 2.47e-04 | 10 | 70 | 2 | EFO_0001666 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.75e-04 | 53 | 70 | 3 | C4707243 | |
| Disease | Alzheimer's disease (is_implicated_in) | 2.79e-04 | 132 | 70 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | cortical thickness | 2.84e-04 | 1113 | 70 | 10 | EFO_0004840 | |
| Disease | Major Depressive Disorder | 2.85e-04 | 243 | 70 | 5 | C1269683 | |
| Disease | neuroticism measurement | 2.90e-04 | 909 | 70 | 9 | EFO_0007660 | |
| Disease | Marfan Syndrome | 3.01e-04 | 11 | 70 | 2 | C0024796 | |
| Disease | Unipolar Depression | 3.81e-04 | 259 | 70 | 5 | C0041696 | |
| Disease | Liver Cirrhosis, Experimental | 4.86e-04 | 774 | 70 | 8 | C0023893 | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 7.37e-04 | 17 | 70 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | major depressive disorder (is_implicated_in) | 7.37e-04 | 17 | 70 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | bipolar disorder (is_marker_for) | 9.24e-04 | 19 | 70 | 2 | DOID:3312 (is_marker_for) | |
| Disease | Nerve Degeneration | 1.03e-03 | 83 | 70 | 3 | C0027746 | |
| Disease | Schizophrenia | 1.14e-03 | 883 | 70 | 8 | C0036341 | |
| Disease | tooth agenesis | 1.24e-03 | 22 | 70 | 2 | EFO_0005410 | |
| Disease | age-related macular degeneration | 1.25e-03 | 89 | 70 | 3 | EFO_0001365 | |
| Disease | congenital heart disease (is_implicated_in) | 1.48e-03 | 24 | 70 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | childhood trauma measurement | 1.48e-03 | 24 | 70 | 2 | EFO_0007979 | |
| Disease | Carcinoma, Pancreatic Ductal | 1.48e-03 | 24 | 70 | 2 | C0887833 | |
| Disease | systemic scleroderma (is_implicated_in) | 1.48e-03 | 24 | 70 | 2 | DOID:418 (is_implicated_in) | |
| Disease | cerebrospinal fluid biomarker measurement | 1.56e-03 | 96 | 70 | 3 | EFO_0006794 | |
| Disease | migraine disorder | 1.60e-03 | 357 | 70 | 5 | MONDO_0005277 | |
| Disease | Adenoid Cystic Carcinoma | 1.75e-03 | 100 | 70 | 3 | C0010606 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.25e-03 | 566 | 70 | 6 | EFO_0007660, EFO_0008354 | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 2.30e-03 | 110 | 70 | 3 | EFO_0803335 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ECDLPEWCNGTSHKC | 461 | Q9UKF5 | |
| ASCVVWKCCEDGTLE | 391 | P16452 | |
| CCDCGAADPTWLSTN | 441 | Q8TDY4 | |
| CPFCRCEIKGWEAVS | 386 | Q9ULV8 | |
| CPFWAEDGHCSIKDC | 81 | Q86YB8 | |
| WKQCPSCGAICTNTI | 2286 | Q7Z2Y8 | |
| DTCCQLTSGEWGCCP | 376 | P28799 | |
| VCWCPSDFTKIATCS | 366 | Q9NZJ0 | |
| CSIGAVWGVECEACP | 941 | Q75N90 | |
| TKEKTLCCWFCTSGP | 176 | Q96B67 | |
| SETGYWITCCPTCDV | 411 | P55895 | |
| SSCCKWGCSKSEISS | 126 | Q8WXF3 | |
| CITAWCSSKAECPLC | 296 | O60683 | |
| PTGLVFSNSCKCCTW | 451 | Q13231 | |
| WKPDSCQSCRCHGDI | 41 | Q86XX4 | |
| SCAGCWGPTEKHCLA | 516 | Q86XX4 | |
| KECDWSCSACSGPLK | 956 | Q86XX4 | |
| GEVSCCWTCTPCKEN | 526 | P41594 | |
| ECIPWKDNACCTLTT | 46 | A6ND01 | |
| KCNSGRCIPEHWTCD | 1021 | Q07954 | |
| CECSENWKGEACDIP | 271 | O75882 | |
| KECPACVETGCAWCK | 596 | O60486 | |
| CQDAKWSCTEALCPG | 801 | Q7Z5P9 | |
| WSCTEALCPGRCKVE | 806 | Q7Z5P9 | |
| TSVGCNECTCIKGSW | 1251 | Q7Z5P9 | |
| GSCKDDINSYECWCP | 106 | P00740 | |
| GVCKWPGCESICEDF | 346 | O15409 | |
| GVCKWPGCEAVCEDF | 306 | Q9H334 | |
| SECFSSPKTGFWDCC | 456 | Q5W0B1 | |
| DGEASTPRCKWCTNC | 1946 | Q7Z7M0 | |
| GEICTVDPCHKFTWC | 251 | Q8WX92 | |
| SKCHQETVSLCCPGW | 196 | A0A1B0GTW7 | |
| ENSTEPWFCDACKCG | 366 | O94880 | |
| AVACTVACCKSRTDW | 221 | Q6ZVX9 | |
| VCETSTCDIPVCWTK | 3116 | Q5VST9 | |
| SSCRECIESGPGCTW | 31 | P05107 | |
| AACWTCGFLCPISEV | 146 | Q8NGY6 | |
| SCCCSLGKAWGTPCE | 1561 | P35555 | |
| VCSTSWANTDKCCEL | 1421 | Q05707 | |
| CPLWGKCDAESSKCV | 776 | P10643 | |
| FVGRCCQTCTPKSWE | 46 | Q6NUI2 | |
| TEWPDGAKDCACSCH | 1841 | Q3T8J9 | |
| SWKPDVCTSCICIDS | 766 | Q9NZV1 | |
| CSPWKKNACCTASTS | 51 | P14207 | |
| NDICCDCGSSEPTWL | 451 | Q9ULH1 | |
| CCCSRVGKAWGSECE | 696 | Q14767 | |
| CCAVGAAWGTECEEC | 1026 | P35556 | |
| CVPASWRCDGEKDCE | 141 | Q14114 | |
| KWTCCSKEVCGCDTT | 1926 | Q3ZCN5 | |
| FTCVCKEGWEGPICA | 766 | P78504 | |
| EDCNTCTCTSGKWEC | 491 | Q6ZRI0 | |
| GKWECSTAVCPAECS | 501 | Q6ZRI0 | |
| WQACTCPVGVACDSV | 696 | O75095 | |
| ENIICSCISPCGSWI | 391 | Q969X6 | |
| LCWEGSVSCEPKACA | 751 | Q6ZWJ8 | |
| AGVCSCDPKWTGSDC | 676 | Q9UKZ4 | |
| CDPKWTGSDCSTELC | 681 | Q9UKZ4 | |
| GAPCQECSRCSLWTD | 721 | Q9NWF9 | |
| SCVCDVGWTGPECEA | 676 | Q99466 | |
| PKDATDWCCQTHDCC | 56 | Q9UNK4 | |
| GVACSGSDPSWKCIC | 231 | O76071 | |
| CFWETQPLGCVKISC | 11 | Q8NA57 | |
| WRAAFACPTSCKCSA | 26 | Q16620 | |
| ACPTSCKCSASRIWC | 31 | Q16620 | |
| YNCSTCKGTEVSCWP | 116 | Q3KNT9 | |
| WIPDTNDEKVSACCC | 111 | A0A1B0GUW6 | |
| CKPLFWVCDSVNDCG | 501 | Q9Y5Y6 | |
| PQKWCCLECATTESV | 21 | Q70CQ1 | |
| EPGCSQCWCEDGKVT | 401 | Q96DN2 | |
| ESLWVKSCSFTAACC | 316 | P13489 | |
| WTGPDCSNEICSVDC | 671 | Q9P273 | |
| SCGTDWDIVRKCICA | 1061 | Q92620 | |
| KRPIGSWECSVCCVS | 791 | P49790 | |
| GRDCSPTCWEQGKCS | 281 | Q86YV5 | |
| ADTRCGCKPGWFVEC | 111 | Q93038 | |
| CAWRVFSDTAKCPVC | 226 | Q96EH8 | |
| PCEECGCSFSWKSQL | 396 | Q9NWS9 | |
| LCNIPCSTDCIVSSW | 476 | Q9C0I4 | |
| PSCSWEAEGLHCSCS | 451 | Q96LC7 | |
| TSPTAYCDCWEKCKC | 1226 | O95071 | |
| SECDIWDGQPVCKCK | 121 | Q8TEU8 |